Abivax (AAVXF) Total Debt (2021 - 2025)

Abivax has reported Total Debt over the past 5 years, most recently at $37.4 million for Q4 2025.

  • Quarterly results put Total Debt at $37.4 million for Q4 2025, down 22.2% from a year ago — trailing twelve months through Dec 2025 was $37.4 million (down 22.2% YoY), and the annual figure for FY2025 was $36.3 million, down 25.45%.
  • Total Debt for Q4 2025 was $37.4 million at Abivax, down from $48.0 million in the prior quarter.
  • Over the last five years, Total Debt for AAVXF hit a ceiling of $48.0 million in Q4 2024 and a floor of $13.0 million in Q4 2021.
  • Median Total Debt over the past 5 years was $37.6 million (2022), compared with a mean of $36.5 million.
  • Biggest five-year swings in Total Debt: surged 189.42% in 2022 and later fell 22.2% in 2025.
  • Abivax's Total Debt stood at $13.0 million in 2021, then surged by 189.42% to $37.6 million in 2022, then increased by 23.76% to $46.5 million in 2023, then grew by 3.29% to $48.0 million in 2024, then fell by 22.2% to $37.4 million in 2025.
  • The last three reported values for Total Debt were $37.4 million (Q4 2025), $48.0 million (Q4 2024), and $46.5 million (Q4 2023) per Business Quant data.